Arrivent Biopharma, INC. (AVBP) — 8-K/A Filings
All 8-K/A filings from Arrivent Biopharma, INC.. Browse 1 Amended Current Event Report reports with AI-powered summaries and risk analysis.
8-K/A Filings (1)
-
ArriVent BioPharma Files 8-K/A Amendment
— Jul 9, 2024 Risk: low
ArriVent BioPharma, Inc. filed an amendment (8-K/A) on July 9, 2024, to its report originally dated April 20, 2024. This amendment pertains to the departure of
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX